脑梗塞患者采用灯盏花素注射液治疗前后MMSE积分、BBS积分及血脂水平

MMSE points, BBS score and lipid levels of patients with Cerebral infarction before and after treatment with Breviscapine injection

目的 :探究脑梗塞患者采用灯盏花素注射液治疗前后其mmSe积分、BBS积分及血脂水平的变化情况,分析其临床治疗效果。方法：随机选取2013年12月~2014年12月期间在我院接受治疗的100例脑梗塞患者为研究对象,并将所选患者随机分为对照组和实验组,每组各50例,其中对照组患者给予右旋糖酐加丹参注射液治疗,对照组患者给予灯盏花素加葡萄糖注射液治疗,治疗一个月后,分别采用mmSe积分和BBS积分对两组患者进行认知功能和行为能力的客观评价,对比分析两组患者治疗前后的mmSe积分和BBS积分变化情况以及血脂水平的变化。结果 :实验组患者与对照组患者治疗前的meSS积分和BBS积分和血脂水平对比差异无统计学意义,两组治疗后的meSS积分和BBS积分和血脂水平对比差异显著,具有统计学意义。实验组患者的临床疗效(96%)明显优于对照组(86%),两组对比具有统计学意义。结论 :灯盏花素治疗脑梗塞具有良好的治疗效果,能够显著改善患者的mmSe积分和BBS积分变化情况以及血脂水平,值得临床推广。

Objective To explore the change of MMSE scores, BBS points and blood lipid levels on cerebral infarction pa-tients before and after treating with Breviscapine Injection. Methods 100 patients with cerebral infarction treated in our hospital from December 2013 to December were randomly selected as the research object, and the selected patients were randomly di-vided into control group and experimental group, each group with 50 cases. Patients in control group were treated with dextran and Danshen injection, while the control group with Breviscapine and glucose injection, a month after treatment, respectively, MMSE and BBS integrals were used to evaluate the cognitive function and behavior, and the scores change of MMSE, BBS and blood lipid level before and after treatment were analyzed. Results there was no significant difference in MESS scores and BBS scores between the experimental group and the control group before treatment, however, it’s actively different after treating and after statistic analysis, The clinical efficacy of the experimental group (96%) was significantly better than the control group (86%), the two groups were statistically significant. Conclusion Breviscapine in the treatment of cerebral infarction has a good thera-peutic effect, and it can significantly improved the scores of MMSE, BBS and lipid levels, it’s worthy of clinical promotion.